摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[5-(4-Aminonaphthalen-1-yl)pyridin-2-yl]-(1-methylpiperidin-4-yl) amine | 294852-94-1

中文名称
——
中文别名
——
英文名称
[5-(4-Aminonaphthalen-1-yl)pyridin-2-yl]-(1-methylpiperidin-4-yl) amine
英文别名
5-(4-Amino-1-Naphthalenyl)-N-(1-methyl-4-piperidinyl)-2-pyridinamine;5-(4-aminonaphthalen-1-yl)-N-(1-methylpiperidin-4-yl)pyridin-2-amine
[5-(4-Aminonaphthalen-1-yl)pyridin-2-yl]-(1-methylpiperidin-4-yl) amine化学式
CAS
294852-94-1
化学式
C21H24N4
mdl
——
分子量
332.448
InChiKey
BETVEDQLLUFQPU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    519.0±50.0 °C(Predicted)
  • 密度:
    1.198±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    54.2
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Compounds useful as anti-inflammatory agents
    申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
    公开号:US06608052B2
    公开(公告)日:2003-08-19
    Disclosed are novel aromatic compounds of the formula(I) wherein G, E, W, Ar, X, Y and Z. The compounds are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are pharmaceutical compositions containing and processes of making such compounds.
    揭示了一种新的芳香化合物,其化学式为(I),其中G、E、W、Ar、X、Y和Z。这些化合物可用于治疗涉及炎症的疾病或病理状况,如慢性炎症性疾病。还公开了含有这些化合物的药物组合物以及制备这些化合物的方法。
  • Intermediate arylamine compounds
    申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
    公开号:US20030225077A1
    公开(公告)日:2003-12-04
    Disclosed are novel aromatic compounds which are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are and pharmaceutical compositions containing, intermediate compounds and processes of making such compounds.
    本发明涉及一种新型芳香化合物,可用于治疗涉及炎症的疾病或病理状况,如慢性炎症性疾病。还公开了含有该化合物的制药组合物、中间体化合物和制备该化合物的过程。
  • Heterocyclic urea and related compounds useful as anti-inflammatory agents
    申请人:BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
    公开号:EP1466906A1
    公开(公告)日:2004-10-13
    Disclosed are novel aromatic compounds which are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.
    所公开的新型芳香族化合物可用于治疗涉及炎症(如慢性炎症性疾病)的疾病或病理状况的药物组合物中。还公开了制造此类化合物的工艺。
  • HETEROCYCLIC UREA AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS
    申请人:BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
    公开号:EP1165516B1
    公开(公告)日:2004-10-06
  • UREA COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS
    申请人:BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
    公开号:EP1381594A1
    公开(公告)日:2004-01-21
查看更多